These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25697187)

  • 1. Feasibility of immuno-PCR technology platforms as an ultrasensitive tool for the detection of anti-drug antibodies.
    Jani D; Savino E; Goyal J
    Bioanalysis; 2015; 7(3):285-94. PubMed ID: 25697187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
    Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
    J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-PCR assays for immunogenicity testing.
    Spengler M; Adler M; Jonas A; Niemeyer CM
    Biochem Biophys Res Commun; 2009 Sep; 387(2):278-82. PubMed ID: 19577544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hapten labeling of nucleic acids for immuno-polymerase chain reaction applications.
    Adler M
    Methods Mol Biol; 2004; 283():163-80. PubMed ID: 15197309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol.
    Case MC; Burt AD; Hughes J; Palmer JM; Collier JD; Bassendine MF; Yeaman SJ; Hughes MA; Major GN
    J Immunol Methods; 1999 Feb; 223(1):93-106. PubMed ID: 10037237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-PCR: An ultrasensitive immunoassay for biomolecular detection.
    Chang L; Li J; Wang L
    Anal Chim Acta; 2016 Mar; 910():12-24. PubMed ID: 26873464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical immunogenicity specificity assessments: a platform evaluation.
    Peng K; Siradze K; Quarmby V; Fischer SK
    J Pharm Biomed Anal; 2011 Feb; 54(3):629-35. PubMed ID: 21035975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.
    Partridge MA; Purushothama S; Elango C; Lu Y
    J Immunol Res; 2016; 2016():6262383. PubMed ID: 27556048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
    Li J; Schantz A; Schwegler M; Shankar G
    J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A.
    Chao HY; Wang YC; Tang SS; Liu HW
    Toxicon; 2004 Jan; 43(1):27-34. PubMed ID: 15037026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorometric polymerase chain reaction (PCR) enzyme-linked immunosorbent assay for quantification of immuno-PCR products in microplates.
    Niemeyer CM; Adler M; Blohm D
    Anal Biochem; 1997 Mar; 246(1):140-5. PubMed ID: 9056198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.
    Liu Y; Reidler H; Pan J; Milunic D; Qin D; Chen D; Vallejo YR; Yin R
    J Pharmacol Toxicol Methods; 2011; 64(3):238-45. PubMed ID: 21827863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of three real-time immuno-PCR assemblages for quantification of PSA.
    Lind K; Kubista M
    J Immunol Methods; 2005 Sep; 304(1-2):107-16. PubMed ID: 16111699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immuno-PCR: a promising ultrasensitive diagnostic method to detect antigens and antibodies.
    Malou N; Raoult D
    Trends Microbiol; 2011 Jun; 19(6):295-302. PubMed ID: 21478019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of enzyme linked immuno-sorbent assay for cytomegalovirus disease.
    Priya K; Madhavan HN
    J Postgrad Med; 2002; 48(3):176-8; discussion 190. PubMed ID: 12432189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Clostridium botulinum neurotoxin type A using immuno-PCR.
    Wu HC; Huang YL; Lai SC; Huang YY; Shaio MF
    Lett Appl Microbiol; 2001 May; 32(5):321-5. PubMed ID: 11328498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vailidation of immunoassays for anti-drug antibodies.
    Van Cleave VH
    Dev Biol (Basel); 2003; 112():107-12. PubMed ID: 12762509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
    Smith HW; Butterfield A; Sun D
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immuno-PCR method for detecting Bacillus thuringiensis Cry1Ac toxin.
    Allen RC; Rogelj S; Cordova SE; Kieft TL
    J Immunol Methods; 2006 Jan; 308(1-2):109-15. PubMed ID: 16337224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG-detection devices for the Tus-Ter-lock immuno-PCR diagnostic platform.
    Morin I; Askin SP; Schaeffer PM
    Analyst; 2011 Nov; 136(22):4815-21. PubMed ID: 21980595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.